Eva Hapetta

junior scientist at Chembio Diagnostic Systems Inc

Eva Hapetta's Professional Contact Details

Email (Verified)

****@chembio.com

Get Email Address

(631) 924-1135

Location

Farmingville, New York, US

Company

Chembio Diagnostic Systems Inc

Person Seniority

entry

Eva Hapetta's Current Company Details

Chembio Diagnostic Systems Inc

Medford, New York, US • 58 Employees

medical devices

Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $10 billion point-of-care testing market. Chembio's three FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the US: SURE CHECKÂ® HIV 1/2, HIV 1/2 STAT-PAKÂ® and DPPÂ® HIV 1/2 assays. Chembio markets its DPPÂ® HIV-Syphilis assay and other rapid tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPPÂ®) technology, which has advantages over lateral-flow technologies when it comes to multiplexing and working with challenging matrices. This technology provides Chembio with a significant pipeline of business opportunities for the development and manufacture of new products. Headquartered in Medford, NY, with approximately 150 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U. S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.

Public Symbol

CEMI

Founded Year

1986

Organization Website

chembio.com

Organization Languages

English

Organization Revenue

17900

Current Technologies

hubspot